ROIV ROIVANT SCIENCES LTD Other Situations 8-K Filing 2023 - Announcement of Clinical Trial Data Roivant Sciences Ltd. announced initial data from Immunovant's Phase 1 clinical trial of IMVT-1402 for autoimmune diseases, with a conference call and webcast scheduled for November 28, 2023.Get access to all SEC 8-K filings of the ROIVANT SCIENCES LTD